Northwestern Mutual Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
CCA
Northwestern Mutual Wealth Management's IDNA Position: Q1 2026 in Review
Northwestern Mutual Wealth Management reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 3.8% in Q1 2026, selling an estimated $581 and leaving 500 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.
Northwestern Mutual Wealth Management first reported a position in IDNA in Q2 2021 and has held it in 11 quarters since. The position peaked at $25K in Q2 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.
- Northwestern Mutual Wealth Management held 500 shares of iShares Genomics Immunology and Healthcare ETF worth $14.5K as of Q1 2026.
- Northwestern Mutual Wealth Management sold 20 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $581.
- iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2927 holding.
- Northwestern Mutual Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2021 and has held it in 11 quarters since.
- Northwestern Mutual Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $25K in Q2 2021.
- 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.